European Study on Prediction of Outcome in Patients With Idiopathic Normal Pressure Hydrocephalus

NCT00874198 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 156

Last updated 2009-04-03

No results posted yet for this study

Summary

The purpose of the study is to determine the predictive values and prognostic accuracies of CSF dynamic measures, the TAP -TEST (high-volume cerebrospinal fluid withdrawal), resistance to CSF outflow and compliance in the prediction of shunt-treatment outcome in patients with idiopathic normal pressure hydrocephalus.

Conditions

  • Normal Pressure Hydrocephalus

Interventions

PROCEDURE

Ventriculo-peritoneal Shunt

Surgical implantation of a ventriculo-peritoneal cerebrospinal fluid shunt with an adjustable valve system using the Codman-Hakim programmable valve system \[pressure settings: 30 - 200 mmH20\]

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    collaborator OTHER
  • Department of Neurology and Neurosurgery,Westeinde Hospital, Den Haag

    collaborator UNKNOWN
  • Uppsala University Hospital

    collaborator OTHER
  • University of Copenhagen

    collaborator OTHER
  • Unfallkrankenhaus Berlin

    collaborator OTHER
  • Universität des Saarlandes

    collaborator OTHER
  • University of Padova

    collaborator OTHER
  • Masaryk University

    collaborator OTHER
  • University of Budapest

    collaborator OTHER
  • Hospital Universitari de Bellvitge

    collaborator OTHER
  • Hospital General Universitario Gregorio Marañon

    collaborator OTHER
  • Neurosurgical Department, Clinique St. Jaen, Brussels, Belgium

    collaborator UNKNOWN
  • International Neuroscience Institute Hannover

    lead OTHER

Principal Investigators

  • Petra M Klinge, MD · International Neuroscience Institute Hannover

  • Carsten I Wikkelsoe, MD · Sahlgrenska University, Gothenburg, Sweden

  • Jos TH Tans, MD · Westeinde Hospital, Den Haag, Netherlands

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2008-03-31
Completion
2009-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00874198 on ClinicalTrials.gov